■未使用的药物处置不当会对环境造成影响,造成重大的医疗保健和经济负担。虽然药品回收计划是一项有效的管理策略,其效果因国家而异。这项研究旨在系统地审查各国的收回方案,并确定需要改进方案的领域。
■我们在Medline进行了搜索,EMBASE,CINAHL,WebofScience,Scopus,和谷歌学者,从数据库开始到2023年6月。
■该综述包括15个国家/地区的27项研究。虽然有些方案,主要在美国观察到,在地方一级与非卫生相关设施进行,其他是在国家一级的医疗机构内完成的。收缴药物的费用从7,416美元到1,118,020美元不等,主要涉及与神经系统有关的药物,心血管系统,消化道,和新陈代谢。与这些计划有关的立法在美国可用,大多数欧洲国家,墨西哥,但在西班牙找不到,奥地利,澳大利亚,和新西兰。然而,尽管如此,这些国家的政府或行业管理这些计划。
■结构良好的回收计划,具有易于访问的收集点,定期收集时间表,明确的方案所有权,通过立法界定财务责任,显示出积极的结果。
UNASSIGNED: Improper disposal of unused medicine can impact the environment causing significant healthcare and financial burdens. While the medicine take-back programme is an effective management strategy, its effectiveness differs across countries. This study aimed to systematically
review the take-back programmes in various countries and to identify areas needing improvement for programme enhancement.
UNASSIGNED: We conducted searches in Medline, EMBASE, CINAHL, Web of Science, Scopus, and Google Scholar, from database inception to June 2023.
UNASSIGNED: The
review included 27 studies spanning 15 countries\' medicine take-back programmes. While some programmes, mostly observed in the USA, were conducted at the local level with non-health-associated facilities, others were done at the national level within healthcare facilities. The cost of collected medicines ranged from US$7,416 to US$1,118,020, primarily involving medicines related to the nervous system, cardiovascular system, alimentary tract, and metabolism. Legislations pertaining to these programmes were available in the USA, most European countries, and Mexico, but unavailable in Spain, Austria, Australia, and New Zealand. However, despite this, the government or the industry in these countries managed the programmes.
UNASSIGNED: Well-structured take-back programmes featuring easily accessible collection points, regular collection schedules, clear programme ownership, with
legislation defining financial responsibilities, showed positive outcomes.